SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 41.62% to Rs. 3466.67 millions for the June 2023 quarter as compared to Rs. 2447.81 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -157.03 millions as compared to Net Loss of Rs. -232.79 millions of corresponding quarter ended June 2022The company reported a good operating profit of 141.35 millions compared to 9.58 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3466.67 2447.81 41.62 3466.67 2447.81 41.62 10724.32 9429.27 13.73
Other Income 58.26 118.45 -50.81 58.26 118.45 -50.81 418.48 420.68 -0.52
PBIDT 141.35 9.58 1375.47 141.35 9.58 1375.47 -510.65 -14.86 3336.41
Interest 24.75 16.67 48.47 24.75 16.67 48.47 93.80 20.74 352.27
PBDT 116.60 -7.09 -1744.57 116.60 -7.09 -1744.57 -1731.09 -35.60 4762.61
Depreciation 273.63 225.70 21.24 273.63 225.70 21.24 1059.79 831.88 27.40
PBT -157.03 -232.79 -32.54 -157.03 -232.79 -32.54 -2790.88 -867.48 221.72
TAX 0.00 0.00 0.00 0.00 0.00 0.00 206.12 -313.18 -165.82
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 206.12 -315.55 -165.32
PAT -157.03 -232.79 -32.54 -157.03 -232.79 -32.54 -2997.00 -554.30 440.68
Equity 140.81 140.81 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 4.08 0.39 941.75 4.08 0.39 941.75 -4.76 -0.16 2921.32

Unichem Lab Share Price

345.00 -5.85 (-1.67%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×